申请人:Turner Sean Colm
公开号:US20120172376A1
公开(公告)日:2012-07-05
The present invention relates to novel heterocyclic compounds of formula I
wherein the variables are as defined in the claims or the description,
which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), compositions containing the compounds, their use for preparing a medicament for the treatment of a medical disorder susceptible to the treatment with a compound that modulates, preferably inhibits, the activity of glycogen synthase kinase 3β, and methods of treatment of medical disorders susceptible to treatment with a compound that modulates glycogen synthase kinase 3β activity using the compounds.
本发明涉及式I的新颖杂环化合物,其中变量如权利要求或说明书中所定义,这些化合物可用于抑制糖原合酶激酶3(GSK-3),包含这些化合物的组合物,以及使用这些化合物制备用于治疗对调节、优选抑制GSK-3β活性化合物敏感的医疗病症的药物的用途,以及使用这些化合物治疗对调节GSK-3β活性化合物敏感的医疗病症的方法。